Processa Pharmaceuticals, Inc. (PCSA) Insider Trading & SEC Filings

Updated Jul 16, 2026 · Last SEC filing 2026-07-01

Processa Pharmaceuticals, Inc. (PCSA) has filed 37 SEC Form 4 insider transactions in the last 90 days, with the most recent on 2026-07-01. 1 Form 8-K material event filings were reported by PCSA in the last 90 days. InsiderAlpha tracks every PCSA SEC filing — Form 4, Form 144, and 8-K — in real time, including Rule 10b5-1 plan detection.

About Processa Pharmaceuticals, Inc. (PCSA)

SIC classificationPharmaceutical Preparations (SIC 2834)
SEC CIK0001533743

90-Day SEC Filing Activity

Form 4 filings (90d)37
Form 8-K filings (90d)1
Latest Form 4 filing2026-07-01

Recent PCSA Insider Transactions (Form 4)

DateInsiderRoleTransactionSharesPriceValueFiling
Ng George KChief Executive OfficerP — Open-market purchase3.1K$1.93$6KSEC
Lin PatrickChief Business - Strategy OffP — Open-market purchase2.1K$1.93$4KSEC
SKIBSTED RUSSELLChief Financial OfficerP — Open-market purchase3.3K$1.93$6KSEC
Guy WendyChief Administrative OfficerP — Open-market purchase2.4K$1.93$5KSEC
Young DavidPres. Research & DevelopmentP — Open-market purchase2.5K$1.93$5KSEC
Baluch KhosoInsiderM — Option exercise203——SEC
Neal James RInsiderM — Option exercise203——SEC
Yorke Justin WInsiderM — Option exercise203——SEC
Pannu GeraldineInsiderM — Option exercise203——SEC
Lin PatrickChief Business - Strategy OffP — Open-market purchase1.8K$2.22$4KSEC
Guy WendyChief Administrative OfficerP — Open-market purchase2.1K$2.22$5KSEC
Ng George KChief Executive OfficerP — Open-market purchase2.5K$2.22$5KSEC
Young DavidPres. Research & DevelopmentP — Open-market purchase2.1K$2.22$5KSEC
SKIBSTED RUSSELLChief Financial OfficerP — Open-market purchase2.7K$2.22$6KSEC
Young DavidPres. Research & DevelopmentP — Open-market purchase1.8K$2.57$5KSEC

All transactions sourced from SEC EDGAR Form 4 filings for Processa Pharmaceuticals, Inc. (PCSA). Updated in real time as new filings are submitted to the SEC.

Most-Active PCSA Insiders — Last 90 Days

InsiderForm 4 filingsTotal transaction value
SKIBSTED RUSSELL6$36K
Young David6$28K
Ng George K6$33K
Lin Patrick6$24K
Guy Wendy6$28K

Recent PCSA Form 8-K Material Events

Recent Insider Filings

Form 4 Transaction Code Reference

SEC Form 4 transactions are reported with a one-letter code indicating the type of transaction. Common codes you'll see in PCSA insider filings:

POpen-market purchase by the insider
SOpen-market sale by the insider
AGrant, award, or other acquisition from the issuer
MExercise or conversion of derivative security (e.g. options)
FPayment of exercise price or tax liability via share withholding
GBona-fide gift of securities
DDisposition to the issuer (e.g. share buyback participation)
JOther acquisition or disposition
XExercise of in-the-money or at-the-money derivative security
CConversion of derivative security
VTransaction voluntarily reported earlier than required

PCSA Insider Trading — FAQ

What is the latest insider trade for PCSA?
Processa Pharmaceuticals, Inc. (PCSA) had 37 insider filings in the last 90 days, with the most recent on 2026-07-01. InsiderAlpha tracks every Form 4, 10-K, 10-Q, and 8-K filing in real time.
How many insiders are buying PCSA stock?
0 insider purchases of PCSA were filed in the last 90 days.
How many insiders are selling PCSA stock?
0 insider sales of PCSA were filed in the last 90 days.
Where can I see PCSA SEC filings (Form 4, 10-K, 10-Q, 8-K)?
InsiderAlpha aggregates every PCSA SEC filing — Form 4 insider transactions, 10-K and 10-Q quarterly reports, and 8-K material event disclosures — in one timeline.

Related Companies — Recent Insider Activity

Learn More

Open the live PCSA dashboard on InsiderAlpha for real-time alerts, charting, and full historical filing search.